Norhan M. El‐Sayed

594 total citations
40 papers, 442 citations indexed

About

Norhan M. El‐Sayed is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Surgery. According to data from OpenAlex, Norhan M. El‐Sayed has authored 40 papers receiving a total of 442 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 7 papers in Endocrinology, Diabetes and Metabolism and 6 papers in Surgery. Recurrent topics in Norhan M. El‐Sayed's work include Metabolism, Diabetes, and Cancer (5 papers), Pancreatic function and diabetes (5 papers) and Parkinson's Disease Mechanisms and Treatments (4 papers). Norhan M. El‐Sayed is often cited by papers focused on Metabolism, Diabetes, and Cancer (5 papers), Pancreatic function and diabetes (5 papers) and Parkinson's Disease Mechanisms and Treatments (4 papers). Norhan M. El‐Sayed collaborates with scholars based in Egypt, Saudi Arabia and Kuwait. Norhan M. El‐Sayed's co-authors include Amal A.M. Ahmed, Yasser M. Moustafa, Yasser M. Mostafa, Eman T. Mehanna, Dina M. Khodeer, Mohamed Saleh Elgawish, Sawsan A. Zaitone, Safwat A. Ahmed, Noha M. Abogresha and Reda F. A. Abdelhameed and has published in prestigious journals such as Biochemical Pharmacology, Life Sciences and Neuropharmacology.

In The Last Decade

Norhan M. El‐Sayed

38 papers receiving 435 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Norhan M. El‐Sayed Egypt 14 159 67 60 52 52 40 442
Nayira A. Abdel Baky Egypt 13 144 0.9× 67 1.0× 68 1.1× 61 1.2× 33 0.6× 31 506
Anoop Kishore India 13 154 1.0× 45 0.7× 53 0.9× 38 0.7× 32 0.6× 52 494
Syed Sanober Qadri India 2 182 1.1× 35 0.5× 93 1.6× 54 1.0× 31 0.6× 5 534
Raksha Rani India 2 187 1.2× 34 0.5× 93 1.6× 54 1.0× 31 0.6× 2 552
Oľga Vančová Slovakia 13 221 1.4× 63 0.9× 122 2.0× 54 1.0× 55 1.1× 36 596
Ahmed M. Ashour Saudi Arabia 14 163 1.0× 37 0.6× 41 0.7× 36 0.7× 51 1.0× 50 528
Xuxu Zheng China 10 187 1.2× 56 0.8× 73 1.2× 29 0.6× 52 1.0× 13 417
Maha A.E. Ahmed Egypt 12 174 1.1× 41 0.6× 40 0.7× 60 1.2× 48 0.9× 16 457
Enas M. Moustafa Egypt 14 220 1.4× 32 0.5× 64 1.1× 43 0.8× 47 0.9× 37 520
Esther T. Menze Egypt 17 199 1.3× 42 0.6× 60 1.0× 31 0.6× 44 0.8× 32 659

Countries citing papers authored by Norhan M. El‐Sayed

Since Specialization
Citations

This map shows the geographic impact of Norhan M. El‐Sayed's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Norhan M. El‐Sayed with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Norhan M. El‐Sayed more than expected).

Fields of papers citing papers by Norhan M. El‐Sayed

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Norhan M. El‐Sayed. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Norhan M. El‐Sayed. The network helps show where Norhan M. El‐Sayed may publish in the future.

Co-authorship network of co-authors of Norhan M. El‐Sayed

This figure shows the co-authorship network connecting the top 25 collaborators of Norhan M. El‐Sayed. A scholar is included among the top collaborators of Norhan M. El‐Sayed based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Norhan M. El‐Sayed. Norhan M. El‐Sayed is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
El‐Fayoumi, Hassan M., et al.. (2025). Overview of key molecular processes behind diabetic nephropathy. 9(3). 32–39.
2.
Abdelhamid, A. M., et al.. (2024). Alpha-Asarone attenuates alcohol-induced hepatotoxicity in a murine model by ameliorating oxidative stress, inflammation, and modulating apoptotic-Autophagic cell death. Toxicology and Applied Pharmacology. 490. 117041–117041. 2 indexed citations
3.
El‐Sayed, Norhan M., et al.. (2024). Cardioprotective Effects of α-Asarone Against Hexavalent Chromium-Induced Oxidative Damage in Mice. Drug Design Development and Therapy. Volume 18. 3383–3397. 2 indexed citations
4.
Moustafa, Yasser M., et al.. (2024). Doxepin as OCT2 inhibitor ameliorates inflammatory response and modulates PI3K/Akt signaling associated with cisplatin-induced nephrotoxicity in rats. Naunyn-Schmiedeberg s Archives of Pharmacology. 398(4). 3995–4008. 3 indexed citations
6.
El‐Sayed, Norhan M., et al.. (2023). Niclosamide modulates cyclosporin A-induced hepatotoxicity in a mouse model: PPAR-γ and Wnt/β-catenin crosstalk. International Immunopharmacology. 117. 109941–109941. 2 indexed citations
7.
Mehanna, Eman T., et al.. (2023). Antitumor effect of trimetazidine in a model of solid Ehrlich carcinoma is mediated by inhibition of glycolytic pathway and AKT signaling. Chemico-Biological Interactions. 383. 110672–110672. 2 indexed citations
8.
Elsayed, Mohammed, et al.. (2023). Empagliflozin protects against isoprenaline-induced fibrosis in rat heart through modulation of TGF-β/SMAD pathway. Life Sciences. 337. 122354–122354. 6 indexed citations
9.
Mostafa, Yasser M., et al.. (2023). Arctigenin improves neuropathy via ameliorating apoptosis and modulating autophagy in streptozotocin‐induced diabetic mice. CNS Neuroscience & Therapeutics. 29(10). 3068–3080. 16 indexed citations
10.
Elsayed, Mohammed, et al.. (2023). Signaling pathways in cardiac fibrosis; A review and future therapeutic options. 7(3). 165–180. 1 indexed citations
12.
Khodeer, Dina M., Basel A. Abdel‐Wahab, Ibrahim Abdel Aziz Ibrahim, et al.. (2023). Canagliflozin alleviates valproic acid-induced autism in rat pups: Role of PTEN/PDK/PPAR-γ signaling pathways. Frontiers in Pharmacology. 14. 1113966–1113966. 8 indexed citations
13.
Mostafa, Yasser M., Eman T. Mehanna, Mona F. El-Azab, et al.. (2022). Pioglitazone Ameliorates Hippocampal Neurodegeneration, Disturbances in Glucose Metabolism and AKT/mTOR Signaling Pathways in Pentyelenetetrazole-Kindled Mice. Pharmaceuticals. 15(9). 1113–1113. 5 indexed citations
14.
Mostafa, Yasser M., et al.. (2021). Dapagliflozin attenuates diabetic cardiomyopathy through erythropoietin up-regulation of AKT/JAK/MAPK pathways in streptozotocin-induced diabetic rats. Chemico-Biological Interactions. 347. 109617–109617. 22 indexed citations
15.
El‐Sayed, Norhan M., et al.. (2020). Nano selenium ameliorates oxidative stress and inflammatory response associated with cypermethrin-induced neurotoxicity in rats. Ecotoxicology and Environmental Safety. 195. 110479–110479. 68 indexed citations
17.
Mehanna, Eman T., Norhan M. El‐Sayed, Amany K. Ibrahim, Safwat A. Ahmed, & Dina M. Abo‐Elmatty. (2018). Isolated compounds from Cuscuta pedicellata ameliorate oxidative stress and upregulate expression of some energy regulatory genes in high fat diet induced obesity in rats. Biomedicine & Pharmacotherapy. 108. 1253–1258. 23 indexed citations
18.
El‐Sayed, Norhan M., et al.. (2018). Donepezil improves neuropathy through activation of AMPK signalling pathway in streptozotocin-induced diabetic mice. Biochemical Pharmacology. 159. 1–10. 33 indexed citations
19.
El‐Sayed, Norhan M., et al.. (2017). Glutamine up-regulates pancreatic sodium-dependent neutral aminoacid transporter-2 and mitigates islets apoptosis in diabetic rats. Pharmacological Reports. 70(2). 233–242. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026